Bontog, Paterno L.

HRN: 18-22-82  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2026
08/14/2026
IV
500mg
Q8
COLONIC ADENOCARCINOMA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: